Molecular subtypes and clinicopathological features of breastcancer

https://doi.org/10.19106/JMedScie004501201306

. Irianiwati(1*)

(1) Department of Anatomical Pathology, Faculty of Medicine, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta
(*) Corresponding Author

Abstract


Breast cancer is a heterogeneous disease with regard to morphological spectrum, clinical presentation and response to therapy. Based on immunohistochemistry detection of estrogen receptor, progesterone receptor, Her-2 status, proliferation rate and clusters of basal gene expression, breast cancers can be classified into luminal A, luminal B, basal-like/triple negative, and Her-2 positive. It was suggested that there was a close relationship between molecular subtypes and clinicopathological features of breast cancer, as they are very important to predict prognosis and therapeutic implications.

 

 


Keywords


molecular subtypes - breast cancer- clinicopathological features -heterogeneity –theraputicimplications




DOI: https://doi.org/10.19106/JMedScie004501201306

Article Metrics

Abstract views : 1090 | views : 1761




Copyright (c) 1970 . Irianiwati

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.